Potential role of natural products in veterinary stem cell therapy Authors: Asiyeh Shojaee Published: 2026 ABSTRACT AbstractIn veterinary medicine, stem cells therapy is mostly used to treatment of orthopedic condition. Stem cell behavior is shaped by numerous intrinsic and extrinsic factors. Traditional medicinal herbs—long used to prevent and treat diverse diseases—together with other natural bioactive compounds have attracted increasing interest because of their potential to modulate stem cell function. Many of these agents exhibit antioxidant, anti-inflammatory, anticancer, and anti-apoptotic activities and may support tissue regeneration by enhancing proliferation, differentiation, and migration. Importantly, natural products may offer safer and more cost-effective alternatives to synthetic growth factors in regenerative strategies. Accordingly, this review summarizes recent evidence on medicinal plants, phytochemicals, algal extracts, and related bioactive compounds that influence veterinary stem cells, and discusses their potential applications in regenerative medicine.Keywords: Bioactive compounds, Herbal medicine, Mesenchymal stem cells, Natural products, Phytochemicals, Regenerative medicine, Veterinary medicine Introduction Stem cell–based therapies have emerged as a transformative frontier in veterinary medicine, offering promising regenerative strategies for a wide range of debilitating conditions in both companion animals and livestock. Among veterinary applications, stem cell therapy is most frequently utilized for orthopedic disorders, particularly in racehorses, where tendon, ligament, and joint injuries are prevalent. The anatomical size and biomechanical properties of equine tissues make them especially suitable for such regenerative interventions, allowing for more precise delivery and evaluation compared to smaller species [1]. These therapies are especially well-suited for the treatment of various disease categories. In clinical veterinary practice, mesenchymal stem cells (MSCs) are most commonly used in dogs and horses for complex musculoskeletal injuries and certain systemic conditions, while in cats they have been increasingly applied to renal, respiratory, and inflammatory disorders. In recent years, their clinical application has expanded considerably, particularly in companion animals, where they have shown potential to improve quality of life and serve as adjuncts to non-pharmacological interventions such as animal-assisted therapy (AAT). moreover, these models also hold significant value as translational systems. While no animal model can fully replicate human clinical conditions, small laboratory animals- particularly rats—remain widely used in preclinical stem cell research due to their genetic similarity to humans, cost-effectiveness, ease of handling, short life cycle, and extensive genetic tools. Therefore, although rodent models are indispensable for early-stage validation, larger animal models often provide superior anatomical and physiological relevance may offer greater translational relevance for specific applications. Building on these advances, optimizing the functional performance of stem cells has become a critical focus. The behavior of these cells is governed by a complex interplay of internal and external factors. While synthetic substances like recombinant cytokines and growth factors are widely used to drive proliferation and differentiation, their clinical application is often hindered by high costs, limited stability, and potential adverse effects. In parallel, the widespread use of fetal bovine serum (FBS) in culture systems presents significant challenges, including high cost, batch-to-batch variability, and the potential for microbial contamination such as bacteria and viruses. Moreover, ethical concerns associated with FBS production, which involves the slaughter of pregnant cows and harvesting of fetal blood, further underscore the need for safer, more sustainable, and cost-effective substitutes [2].These limitations have driven increasing interest in natural products interest as biologically compatible and cost-effective alternatives modulators of stem cell function. A wide range of natural products and their derivatives have demonstrated the ability to influence key signaling pathways involved in stem cell regulation. Incorporating these compounds into stem cell–based strategies may enhance therapeutic outcomes, improve safety profiles, and provide more sustainable approaches for clinical application in veterinary medicine. Moreover, such strategies may further strengthen the translational value of animal models by offering novel, integrative therapeutic paradigms that are applicable to both animal and human health [3]. Despite the growing body of evidence supporting the regulatory effects of natural products on stem cell behavior, a comprehensive and integrative synthesis of these findings within the veterinary context remains lacking. The present review aims to consolidate current knowledge on the role of natural bioactive compounds in modulating the proliferation, differentiation, and functional properties of veterinary-derived stem cells. First, we outline the fundamental principles underlying the optimization of stem cell–based therapies in veterinary species. We then briefly summarize MSC-based therapies used alone, followed by their combination with natural products, each of which is organized under a specific subheading with a description of the related in vitro and in vivo findings (Table 1). Table 1Summary of in vitro and in vivo studies on the effects of natural compounds combined with veterinary MSCsSpecies / Model / Cell TypeStudy typeNatural compoundsProtocol / DosageFollow-upMechanisms of actionKey resultReferencesRabbit / OGD model / BMSCsIn vitroIcariinICA: 0.1, 1, 10 µM; OGD exposure: 6–12 hModulation MAPK signaling pathways; Suppression of ER Stress (GRP78, CHOP, Caspase-12)Cytoprotective effect; Inhibited Apoptosis and suppressed excessive Autophagy induced by OGD stress[21]Rabbit / Knee cartilage injury model / BMSCsIn vivoIcariinIntra-articular injection: 1 mL BMSCs (107 cells) pre-incubated with 10 µM ICA for 72 h; (Once weekly for 3 weeks)8 weeksRegulation of BMP / Smads pathwayStimulated chondrocyte proliferation and BMSC differentiation; Repaired knee cartilage injury[22]Canine / BMSCsIn vitroIcariin;Icariside IIICA: 10− 6 M/L;ICA II: 10− 5 M/LIncreased expression of Runx2, Osteocalcin (OCN), and ALP activity; ICAII activatedPI3K/AKT/mTOR/S6K1 signaling pathwayPromoted osteogenic differentiation;ICA II showed higher potency[23, 55]Rabbit / Knee Osteochondral defects (6 × 3 mm) / SMSC-EVsIn vivoIcariinintra-articular injection: 0.2 mg ICA + 20 µg EVs in 0.5 mL; (Twice each week14 weeksChondrogenic differentiation via Wnt/β-catenin pathway/Up regulation COL2A1Dose-dependent cell proliferation; Cartilage repair in joint bone defect[56]Porcine / articular chondrocytesIn vitroResveratrol20 µMUpregulation of COL IIRegulation of collagen type II protein in different zones of articular cartilage.[25]Canine / TNF-α / β induced inflammation model / AD-MSCsIn vitroResveratrolRES :5 µM for 1 hInhibition of NF- kBsignaling pathway; activation of SIRT1, RunX2Osteogenic differentiation[28]Equine / BM- MSCsIn vitroResveratrolRES :10, 5 µMPromoted progression of the cell cycle of EBM-MSCs into the S phase[57]Equine / EMS / MVs from AD-MSCsIn vitroResveratrol &5- AzacytydineAZA: 0.5 µM;RES: 0.05 µM; 24 hApoptosis Axis: Downregulates pro-apoptotic genes (p53, CASP3, CASP9, BAX) and upregulates anti-apoptotic BCL-2;ER Stress Cascade: Regulates PDIA3, ATF-6, IRE-1, CHOP, EIF2, and PERK;Autophagy & Inflammation: Modulates Beclin-1, LAMP-2, and PI3K; decreases extracellular TNF-α and increases IL-10Ameliorates apoptosis, senescence and endoplasmic reticulum stress[58]Rabbit / induced cell model of TGF-β1 gene silencing / BMSCsIn vitroPanax notoginseng100 mg / Lup-regulating the TGF-β1 expressionPromoting effect on osteogenic differentiation[30]Laying hens / ADSCsIn vitrogenistein20 µg/mLon PLLA Scaffold seeded with cellsUpregulation of Runx2, ALP, COL1A2, and OCNGenistein supports osteogenic induction[31]Rabbit / mandibular defects / Dental pulp stem cellsIn vivoAcemannan (Aloe vera extract|)106 DPSCs (20 µL) pretreat with 8 mg/mL acemannan for 24 h60 daysProliferative and viability effects;accelerated the healing process with osteogenesis[32]Canine / BMSCsIn vitroNaringin10− 6 Mol/LIncreased ALP activityEnhances proliferation and osteogenic differentiation[35]Canine / cell model of premature senescence (3rd & 6th passage) / BMSCsIn vitroCurcumin0.1 µM to 10 µMStemness/Pluripotency: Regulates SOX-2 and Nanog.Senescence Axis: Modulates p16 and p21Autophagy Pathway: Enhances Atg7, Atg12, and LC3-II/LC3 ratioanti-aging effects, improve the colony-forming;increase autophagic activity[59]Canine / melanoma (UCDK9M3 & UCDK9M5); mammary carcinoma (CMT12Q2 & CMT27);Osteosarcoma (D17) cell lineIn vitrocurcumin; lipocurc (liposomal)Curcumin: 25 mg/mL; Lipocurc :6.9 mg/mLAnti-cancer and anti-angiogenic; Enhanced liposomal bioavailability[41]Equine / Neutrophil-induced oxidative stress / muscle derived-MSCsIn vitrocurcumin lysinate incorporated into hydroxypropyl-beta cyclodextrin106 mdMSCs loaded with14, 7, 3.5, 1 µM Encapsulated curcuminAntioxidant potential against the oxidative burst of neutrophil;dose-dependent inhibition of ROS; MPO released by PMNs[60]Canine neoplastic cell lines: (C2; CMT-12; D17)In vitroTurmeric root &rosemary leaf extractsIndividual :6.3 µg/mL;Combination:3.1 µg/mL;Duration: For 36 hInduction of the intrinsic apoptotic pathway:Caspase 3/7 activation,Intracellular curcumin accumulation;SAPK/JNK signaling pathwayCombination: synergistic pro-apoptotic effects[42]Equine / oxidative stress induced by H2O2 or metabolic syndrome / AD-MSCsIn vitroCladophora glomerata methanolic extract1% and 5%Down-regulated p21, p53, Bax and Casp-9 and up-regulation of the survival gene Bcl-2,increased the SOD and CAT activitiesUp-regulated Col2A1, ACAN, COMP, Sox-9, Decorin, miR-140-3p and miR-27bAntioxidant and anti-inflammatory activities;1% chondrogenic differentiation[45, 61]Equine / EMS / ASCIn vitroAstaxanthin extractfrom yeast cells10 and 20 µg/mLAnti-apoptotic signalingImprovement in cell proliferation; Reduces cell apoptosis, Ameliorates oxidative stress;Mitochondrial membrane potential stabilization;[46]Equine / palmitic acid induced-insulin resistance / AD-MSCsIn vitroHaematococcus pluvialis algae water extract (enriched with Mg + 2 ionspalmitic acid: 0.7 mM (24 h)Treatment: 15% extract / 54 µM (48 h)Improve the insulin sensitivity, metabolic and proliferative activity, stress markers and apoptosis-related parameters in insulin resistant cells[62]Equine / Equine metabolic syndrome / AD-MSCs and IECsIn vitroSpirulina platensis water extract5% v/v for 24 hDown-regulated expression of P53, p21, Bax ,Parkin, PINK1Enhanced viability, suppressed senescence, and improved proliferation[63]Rabbit / STZ-induced diabetic model / AD-MSCsIn vivoMatricaria chamomilla L. oil (on PLLA scaffold)Scaffold implanted in the caudal stomach (between pancreas and spleen)21 dayslineage Commitment: Induces differentiation of AD-MSCs into Insulin-Producing Cells (IPCs)manages diabetic progression by lowering serum levels of HDL, LDL, and total cholesterol.[49]Canine D-17 osteosarcoma cell lineIn vitroArtemisia annua hydroalcoholic extract;ArtemisininExtract :65 µM;Artemisinin:548 µMPotent dose -dependent cytotoxic activity;Lower IC50 of extract vs. pure artemisinin (65 µM vs. 548 Μm)[64]Canine mammary carcinoma cell line (CF33)In vitroBerberine10 µMInduces dose- and time-dependent inhibition of tumor cell viability[65]Equine / EMS / AD-MSCsIn vitroCalystegines from Hyoscyamus. albus seeds125 to750 µg/ml for 72regulation ofpro- and anti-apoptotic pathways;reduceROS, Nos; Up-regulated GLUT4 an d IRSImprove EqASC viability and proliferation;suppression of ER stress[66]Ovine / Spermatogonial stem cellsIn vitroHenna0.2 mg/mLAntibacterial activity; no detrimental effect on SSC viability[67]Ram / Spermatogonial stem cellsIn vitroSoybean lecithin0.5, 1 and 1.5%Cryoprotection:maintained colony formation ability and membrane stabilization[68]OGD model: glucose and serum deprivation, SMSC-EVs: Synovial-derived MSC extracellular vesicles, ICA: Icariin, RES: Resveratrol, DPSCs: Dental pulp stem cells, PLLA: Poly-L-Lactic Acid scaffold, MPO: Myeloperoxidase; C2: mastocytoma; CMT-12: mammary carcinoma; D17: osteosarcoma; IECs: intestinal epithelial cells; SSC: Spermatogonial stem cells; ROS: reactive oxygen species; Nos: nitric oxides; IRS: insulin receptor substrate Summary of in vitro and in vivo studies on the effects of natural compounds combined with veterinary MSCs Icariin; Icariside II ICA: 10− 6 M/L; ICA II: 10− 5 M/L Increased expression of Runx2, Osteocalcin (OCN), and ALP activity; ICAII activated PI3K/AKT/mTOR/S6K1 signaling pathway Promoted osteogenic differentiation; ICA II showed higher potency Inhibition of NF- kB signaling pathway; activation of SIRT1, RunX2 Resveratrol & 5- Azacytydine AZA: 0.5 µM; RES: 0.05 µM; 24 h Apoptosis Axis: Downregulates pro-apoptotic genes (p53, CASP3, CASP9, BAX) and upregulates anti-apoptotic BCL-2; ER Stress Cascade: Regulates PDIA3, ATF-6, IRE-1, CHOP, EIF2, and PERK; Autophagy & Inflammation: Modulates Beclin-1, LAMP-2, and PI3K; decreases extracellular TNF-α and increases IL-10 20 µg/mL on PLLA Scaffold seeded with cells Proliferative and viability effects; accelerated the healing process with osteogenesis Stemness/Pluripotency: Regulates SOX-2 and Nanog. Senescence Axis: Modulates p16 and p21 Autophagy Pathway: Enhances Atg7, Atg12, and LC3-II/LC3 ratio anti-aging effects, improve the colony-forming; increase autophagic activity Canine / melanoma (UCDK9M3 & UCDK9M5); mammary carcinoma (CMT12Q2 & CMT27); Osteosarcoma (D17) cell line 106 mdMSCs loaded with 14, 7, 3.5, 1 µM Encapsulated curcumin Antioxidant potential against the oxidative burst of neutrophil; dose-dependent inhibition of ROS; MPO released by PMNs Turmeric root & rosemary leaf extracts Individual :6.3 µg/mL; Combination:3.1 µg/mL; Duration: For 36 h Induction of the intrinsic apoptotic pathway: Caspase 3/7 activation, Intracellular curcumin accumulation; SAPK/JNK signaling pathway Down-regulated p21, p53, Bax and Casp-9 and up-regulation of the survival gene Bcl-2,increased the SOD and CAT activities Up-regulated Col2A1, ACAN, COMP, Sox-9, Decorin, miR-140-3p and miR-27b Antioxidant and anti-inflammatory activities; 1% chondrogenic differentiation Astaxanthin extract from yeast cells Improvement in cell proliferation; Reduces cell apoptosis, Ameliorates oxidative stress; Mitochondrial membrane potential stabilization; palmitic acid: 0.7 mM (24 h) Treatment: 15% extract / 54 µM (48 h) Down-regulated expression of P53, p21, Bax , Parkin, PINK1 Artemisia annua hydroalcoholic extract; Artemisinin Extract :65 µM; Artemisinin:548 µM Potent dose -dependent cytotoxic activity; Lower IC50 of extract vs. pure artemisinin (65 µM vs. 548 Μm) 125 to 750 µg/ml for 72 regulation of pro- and anti-apoptotic pathways; reduce ROS, Nos; Up-regulated GLUT4 an d IRS Improve EqASC viability and proliferation; suppression of ER stress Cryoprotection: maintained colony formation ability and membrane stabilization OGD model: glucose and serum deprivation, SMSC-EVs: Synovial-derived MSC extracellular vesicles, ICA: Icariin, RES: Resveratrol, DPSCs: Dental pulp stem cells, PLLA: Poly-L-Lactic Acid scaffold, MPO: Myeloperoxidase; C2: mastocytoma; CMT-12: mammary carcinoma; D17: osteosarcoma; IECs: intestinal epithelial cells; SSC: Spermatogonial stem cells; ROS: reactive oxygen species; Nos: nitric oxides; IRS: insulin receptor substrate Optimization of stem cell delivery in veterinary context Among various stem cell types, mesenchymal stem cells (MSCs) are widely utilized for therapeutic applications due to their immunosuppressive properties and ease of isolation from diverse tissues [4]. MSCs exhibit source-dependent variations in proliferation, differentiation potential, and secretory profiles, influenced by factors such as donor species, age, harvest site, and health status. To higher therapeutic efficacy, clinicians must be consider optimizing the cell dosage, delivery route, administration timing, targeted disease and organ, and single versus repeated dosing [5]. While higher cell doses are typically expected to maximize therapeutic outcomes, this relationship is not linear. In equine joint therapies, for example, over-dosing MSCs can trigger acute inflammatory flare-ups, aggravating clinical signs instead of promoting recovery [6]. Although intravenous (IV) injection is the most common route, its efficacy can vary. Infused cells often show limited persistence and rapid clearance or pulmonary trapping. Accordingly, some long-term effects of IV-delivered MSCs may be mediated indirectly, including via apoptosis followed by phagocytosis by immune cells [7]. Comparative studies in animal model illustrate this context-specific efficacy. For example, in hepatic models where multiple delivery routes were evaluated, IV delivery emerged as the best route in rats, whereas in pigs, intra-arterial (IA) administration significantly improved cell homing to the liver and reduced pulmonary trapping. However, IA carries a risk of intravascular occlusion and requires higher technical expertise in clinical settings. Choosing the optimal cell source requires careful evaluation of donor–recipient compatibility. The primary concern with allogeneic stem cells is immune recognition by the recipient, which can lead to rejection upon re-exposure [8]. As xenogeneic options are even more controversial, a randomized, double-blind, placebo-controlled trial in a canine model investigated this by reporting that single or repeated IA injections of equine umbilical cord–derived MSCs did not elicit acute cytotoxic immune responses, with owner-reported efficacy persisting for over six months in 59% of treated animals [9]. That study found no significant effect of donor age or sex on efficacy, which contrasts with other literature suggesting these factors may be influential. However, because long-term follow-up was uncontrolled and unmasked, these findings must be interpreted with caution. Interaction natural products and their derivatives with stem cells Natural products are categorized into unaltered natural products and their derivatives. These compounds exhibit a wide range of biological activities, including antioxidant, anti-inflammatory, analgesic, anticancer, and antimicrobial effects, and have traditionally served as a major source of medicine for treating various diseases [10]. Natural products described in this article are particularly medicinal herb include a wide range of extracts from herbal remedies and algal species as well as purified bioactive compounds. Plant-derived active chemical compounds, known as phytochemicals or secondary metabolites, are non-nutritive dietary components that play vital roles in cellular metabolism and are essential for plant-environment interactions, protecting plants against insects and fungi. Phytochemicals are classified into different categories based on their structure or function, including phenolic compounds, alkaloids, saponins, carotenoids, and terpenes [11]. Phenolic compounds are one of the most abundant phytochemicals in plants and include various classes such as polyphenols, phenolic acids, stilbenes (e.g., resveratrol), lignans (phytoestrogens) and flavonoids. Flavonoids, the largest subclass, include flavonols (e.g., quercetin as the most common flavonoid, kaempferol), flavones (e.g., apigenin, luteolin), flavanones (e.g., naringenin, hesperetin), isoflavones (e.g., genistein, daidzein), flavanols (e.g., catechin, epigallocatechin gallate), anthocyanins (e.g., cyanidin, malvidin), and flavonolignans. Despite their diverse benefits, medicinal plants and their derivatives can exert beneficial or harmful effects depending on dosage. Unregulated use poses challenges, including potential phytotoxicity and difficulties standardizing active phytochemical levels, leading to variable therapeutic efficacy [12]. Better understanding of these effects will help us to optimizing the safe and effective application of plant extracts or plant-derived bioactive compounds by limiting inappropriate applications, adjusting therapeutic doses, and controlling toxicity. Therefore, stem cell models could serve as valuable platforms for screening medicinal plant drug and assessing toxicity, and determining the appropriate dosage, timing, and duration of exposure to these compounds [13]. Furthermore, these natural compounds can beneficially modulate stem cell behavior, influencing their proliferation, differentiation, and functional activity. This dual functionality—where stem cells serve both as a bioassay system and as therapeutic targets—highlights their potential for independent or synergistic applications in regenerative strategies [14]. In vitro and in vivo effects of natural bioactive compounds combined with mesenchymal stem cells While MSC therapy has demonstrated considerable promise across a range of veterinary applications, the most robust evidence regarding the effect of natural compounds on MSC behavior is currently concentrated in orthopedic, periodontal, oncologic, and metabolic condition in species such as horses, dogs, and rabbits. MSC-based therapies are widely applied in orthopedic disorders. In equine medicine, stem cell–based approaches have been extensively investigated for tendon injuries, including trauma-induced rupture and inflammation-associated tendinitis. Numerous in vivo studies have demonstrated that MSC therapy enhances tendon repair and improves functional outcomes in horses [1]. Similarly, MSC therapy has been broadly explored for cartilage disorders. Although cartilage damage is often associated with mechanical trauma, metabolic conditions such as obesity and metabolic syndrome play a critical role in its degeneration by promoting chronic inflammation, oxidative stress, and impaired chondrocyte function. Notedly, stem cell therapy has been explored as a strategy to manage equine metabolic syndrome (EMS), a complex disorder characterized by insulin resistance, obesity, oxidative stress, systemic inflammation, and a predisposition to laminitis. In this context, stem cell efficacy may be compromised when cells are derived from EMS. EMS-derived MSCs suffer from premature senescence; thus, in vitro antioxidants preconditioning is essential to restore their functional state and represents a critical step in enhancing their therapeutic potential prior to transplantation. While, in diabetic conditions, the high-glucose environment (hyperglycemia) is the primary factor inducing MSC dysfunction and post-transplantation failure. Therefore, local microenvironment modulation is vital [15]. Osteoarthritis (OA), the most prevalent orthopedic disorder and a major cause of lameness in dogs and horses, represents a primary target for MSC-based interventions. Clinical evidence indicates that intra-articular administration of xenogeneic MSCs (e.g., DogStem; EquiCord) is both safe and effective in canine OA [16]. MSC-based approaches are also effective in hip dysplasia (HD), an inherited condition characterized by joint instability and pain. Administration of autologous stromal vascular fraction (SVF) or allogeneic adipose-derived mesenchymal stem cells (AD-MSCs), particularly via acupoint injection, has been reported as a safe and promising therapeutic strategy [17]. Stem cell–based therapies are increasingly applied in the treatment of bone defects in dogs, including those arising from trauma, inflammation, and neoplastic conditions such as osteosarcoma, the most common primary malignant bone tumor. In a canine osteosarcoma model, the combination of MSCs with carboplatin chemotherapy and recombinant human bone morphogenetic protein-2 (rhBMP-2) reduced tumor mass and neoplastic cell infiltration more effectively than carboplatin alone, while potentially mitigating treatment-related toxicities [18]. Notably, osteosarcoma represents one of several clinically significant malignancies in dogs, alongside mammary tumors, lymphoma, mast cell tumors, and primary or metastatic lung cancers, which may also involve bone either directly or through metastatic spread. Within this context, stem cell–based approaches are being explored not only for bone regeneration but also for their potential modulatory effects on tumor progression and the tumor microenvironment. In addition, stem cell–based strategies show promise in periodontal bone regeneration. Transplantation of periodontal ligament stem cell (PDLSC)-derived cell pellets into bone defects in beagle dogs enhances tissue repair through activation of the TGF-β1/Smad signaling pathway, promoting cell proliferation and differentiation [19]. The modulatory and potential therapeutic effects of combination natural compounds with MSCs mediated through the modulation of molecular mechanisms, as discussed for each compound in the following and in more detail in Table 1. Icariin Icariin, a prominent flavonoid glycoside, is the primary bioactive compound extracted from the traditional Chinese medicinal herb Epimedium brevicornum Maxim. It exhibits multiple pharmacological effects, including anti-osteoporotic and anti-osteoarthritic activities [20]. Icariin has been shown to protect rabbit bone marrow-derived mesenchymal stem cells (BM-MSCs) against apoptosis induced by oxygen, glucose, and serum deprivation. This protective effect is mediated through the suppression of endoplasmic reticulum stress (ER)-mediated autophagy via the modulation of the MAPK signaling pathway [21]. Moreover, an in vivo study showed that the combined application of icariin and BM-MSCs repaired rabbit knee cartilage injury by regulating the BMP/Smads pathway [22]. Icariside II, the primary metabolite formed following the oral administration of icariin, has been reported to enhance the proliferation of canine BM-MSCs and promote their osteogenic differentiation via the PI3K/AKT/mTOR/S6K1 signaling pathway [23] (Table 1). Resveratrol Resveratrol is a natural polyphenolic stilbene compound and a potent antioxidant abundantly found in grape skin and red wine, and it exhibits various biochemical activities [24]. It has been shown to upregulate collagen type II expression in chondrocytes from the superficial and middle zones of porcine articular cartilage in a concentration-dependent manner [25]. Resveratrol exerts anti-osteoarthritic actions by inhibiting pro-inflammatory mediators; in vitro studies have demonstrated that it protects rabbit articular chondrocytes from nitric oxide-induced apoptosis through the NF-κB pathway [26]. Moreover, a two-week IA administration of resveratrol (10–50 µmol/kg/day) in a rabbit osteoarthritis model protected against cartilage destruction by suppressing chondrocyte apoptosis and reducing nitric oxide production, highlighting its chondroprotective potential [27]. Furthermore, resveratrol reversed the suppression of osteogenesis induced by TNF-β- and a Sirt1 inhibitor in canine AD-MSCs by activating Sirt1 and Runx2, thereby promoting osteoblast differentiation [28] (Table 1). Panax notoginseng Panax notoginseng is a well-known traditional Chinese medicinal herb. Its key bioactive components are Panax notoginseng saponins (PNS), a group that includes the well-known ginsenosides. In China, it has been used to treat bone fractures by stimulating alkaline phosphatase activity, down-regulating the expression of RANKL, reducing the formation and activity of osteoclasts, and alleviating inflammatory responses and oxidative stress [29]. It has been reported that PNS promotes the in vitro osteogenic differentiation of rabbit BM-MSCs by up-regulating the expression of TGF-β1. Furthermore, a lentivirus-induced TGF-β1 gene silencing model demonstrated that the suppression of TGF-β1 interrupts these osteogenic effects of PNS [30] (Table 1). Genistein Genistein is a natural phytoestrogen and the predominant isoflavone in soybeans, recognized for its structural similarity to estrogen and its important role in regulating bone metabolism. In a study using laying hen AD-MSCs seeded onto PLLA scaffolds, genistein strongly promoted osteogenic differentiation, as evidenced by the upregulation of both early and late osteogenic markers [31] (Table 1). Given the high prevalence of osteoporosis in laying hens, genistein appears to be a promising bioactive compound for improving skeletal tissue engineering and supporting bone health in poultry. Acemannan Acemannan, a polysaccharide found in the inner leaf gel of Aloe vera (Aloe barbadensis Miller), can stimulate bone and periodontal ligament regeneration and accelerate the proliferation and differentiation of osteoblasts. At concentration of 8 mg/mL, acemannan significantly increased the proliferation of rabbit dental pulp stem cells (DPSCs) after 24 h of incubation and accelerated the healing process and osteogenesis in rabbit mandibular defects after 2 months [32](Table 1). Naringin Naringin is the main active flavonoid compound commonly extracted from citrus fruits and Drynariae rhizoma, a traditional Chinese herbal medicine widely used for preventing bone loss and treating osteoporosis and bone fractures [33] It has been reported that naringin regulates osteogenesis of MSCs by modulating regulators of the Wnt signaling pathway, thereby promoting bone differentiation [34]. A study demonstrated a dose-dependent effect of naringin on the proliferation and osteogenic differentiation of canine BM-MSCs and suggested that the application of naringin as a filling material after tooth extraction can help prevent the absorption of alveolar bone and promote its regeneration. However, further research is necessary to determine the stability and safety of naringin for clinical applications [35] (Table 1). Moringa oleifera Lam Moringa oleifera Lam., an Asian herbal plant, possesses various pharmacological properties, including anti-oxidation, and anti-inflammation. An extract of M. oleifera leaves has been shown to enhance the osteogenic differentiation capacity of porcine BM-MSCs as evidenced by increased alkaline phosphatase activity [36]. Salvia miltiorrhiza Salvia miltiorrhiza, known as Danshen, is a widely used Chinese herbal plant with diverse biological activities, including antithrombotic, antiplatelet aggregation, molluscicidal, antioxidant, antiviral, and antitumor effects [37]. A study involving the injection of MSCs combined with Danshen into the femoral artery of a rabbit model with avascular necrosis of the femoral head demonstrated enhanced revascularization and re-ossification which was mediated by the up-regulated expression of vascular endothelial growth factor (VEGF) and BMP‑2 in the femoral head [38] (Table 1). Curcumin Curcumin is a yellow polyphenolic pigment extracted from Curcuma longa, commonly known as turmeric, a widely used spice in Indian cuisine. It exhibits potent antioxidative, anticancer, antitumor, pro-apoptotic, antiangiogenic, and anti-inflammatory properties [39]. However, its clinical application is limited due to poor bioavailability, which is attributed to low aqueous solubility, limited tissue absorption, rapid metabolism, and fast systemic elimination [40]. Lipocurc is a proprietary liposome-encapsulated formulation of curcumin designed for intravenous administration, achieving high concentrations in lung tissue. In vitro studies have demonstrated that Lipocurc inhibits the viability of canine osteosarcoma, melanoma, and mammary carcinoma cell lines (Table 1). In addition, a pilot clinical study in dogs with naturally occurring pulmonary metastatic neoplasia evaluated intravenous Lipocurc administered at a dose of 10 mg/kg over 8 h, once weekly for four weeks. The results indicated that Lipocurc suppressed tumor cell proliferation and impaired endothelial cell functions critical for angiogenesis, including cell viability, migration, and tube formation. Although the treatment was generally well-tolerated, anemia was reported in a few dogs [41] (Table 1). Rosemary Rosemary leaf extract, rich in carnosic acid, exhibits cytotoxic effects and reduces proliferation in canine osteosarcoma (D17), mastocytoma (C2), and mammary carcinoma (CMT-12) cell lines. Different tumor types exhibited distinct responses to treatments with rosemary and turmeric extracts. The CMT-12 cell line was the most sensitive to the treatment, which was likely due to the sustained activation of the SAPK/JNK signaling pathway involved in apoptosis as well as a higher intracellular accumulation of curcumin. Furthermore, the turmeric extract showed a greater ability to induce apoptosis, as measured by Caspase 3/7 activation. Importantly, the combination of these two extracts induced synergistic pro-apoptotic effects, making them a promising therapeutic strategy for canine cancer management [42] (Table 1). Calebin A Calebin A is a bioactive, non-curcuminoid phenylpropanoid compound derived from turmeric (Curcuma longa L.), known for its anti-inflammatory, antioxidant, and anti-tumor properties [43]. Calebin A has been demonstrated to preserve the tenogenic capacity of canine tenocytes in an inflammatory culture medium by modulating the NF-κB/Scleraxis signaling pathway. This modulation suppresses inflammation and extracellular matrix degradation while promoting the expression of tenogenic markers, suggesting that Calebin A could be a promising natural candidate for preventing or treating tendon pathologies, such as tendinitis [44]. Cladophora glomerata Cladophora glomerata is a green macroalga rich in bioactive polyphenols, widely recognized for its potent antioxidant, anti-inflammatory, and cytoprotective properties. The methanolic extract of C. glomerata has been shown to reduce apoptosis and oxidative stress, and to promote the viability of stem cells derived from EMS. Additionally, this extract enhances chondrogenic differentiation and improves the potential application of equine AD-MSCs for cartilage repair and regeneration. This suggests the therapeutic potential of natural extracts in restoring or enhancing MSC function under metabolic impairments [45]. Astaxanthin Astaxanthin is a carotenoid compound obtained from sources such as Haematococcus pluvialis microalgae and Phaffia rhodozyma yeast. It scavenges reactive oxygen species (ROS) and free radicals, and it has been investigated as an antioxidant strategy to limit oxidative stress–related damage in chronic disease. In equine AD-MSCs obtained from EMS-affected horses, astaxanthin has been shown to reduce oxidative stress and decreases apoptosis [46]. Spirulina platensis Arthrospira platensis (Spirulina) is a nutrient-rich cyanobacterium (commonly referred to as a blue-green alga). Phycocyanin, its major active component, exhibits antioxidant and anti-inflammatory properties. In vivo studies have demonstrated that EMS-affected horses fed a diet supplemented with 500 g of S. platensis daily for three months experienced notable weight loss and improved insulin sensitivity. S. platensis significantly reduces cellular oxidative stress and suppresses senescence and apoptosis in equine AD-MSCs and intestinal epithelial cells (IECs) derived from horses diagnosed with EMS [47]. Matricaria chamomilla Matricaria chamomilla L. is a widely used medicinal plant known for its diverse pharmacological activities. Its secondary metabolites include essential oils rich in sesquiterpenes such as chamazulene and, alpha-bisabolol, flavonoids including apigenin, luteolin, and quercetin, as well as coumarins, mucilages, and vitamins like vitamin C. These compounds act synergistically to provide potent anti-inflammatory, antispasmodic, antioxidant, antimicrobial, analgesic, anxiolytic, and wound-healing effects (oral and dermal) [48]. M. chamomilla essential oil was incorporated into poly (L-lactic acid) (PLLA) scaffolds to investigate its effects on cell adhesion and metabolic parameters in streptozotocin (STZ)-induced diabetic rabbit models. Following 21 days of treatment, a significantly reduction in blood glucose levels and an increase in insulin levels were observed compared to the controls, supporting the potential antidiabetic effects of chamomile oil in enhancing cell therapy [49] (Table 1). Quercetin Quercetin is one of the major flavonoids found in Capparis spinosa (commonly known as the caper bush), Achillea millefolium, and edible plants such as celery, onion, broccoli, and cabbage. It helps reduce inflammation and oxidative stress, which in turn may enhance physical performance. Additionally, quercetin has been found to protect against muscle atrophy in various conditions, including cachexia, obesity, and muscle disuse [50]. Quercetin exhibits a strong pro-differentiation effect by upregulating the expression of myosin heavy chain. In an in vitro culture of porcine muscle stem cells during cultured meat production, a combination of two flavonoids—3,2′-dihydroxyflavone (10 µM) for proliferation and quercetin (50 nM) for differentiation—was used. Quercetin significantly enhances muscle satellite cell differentiation and myotube formation by increasing the gene and protein expression of key myogenic markers. It also suppresses myostatin, a negative regulator of muscle growth, thereby promoting myogenic differentiation and increasing myotube thickness [51]. Luteolin Luteolin is a widely distributed flavonoid compound found in many green leafy vegetables such as parsley, celery and green pepper, as well as in herbs including thyme, rosemary, and oregano. It is present both in its aglycone form and as glycosides, with multiple therapeutic potentials. The biological properties of luteolin include potent antioxidant, anti-cancer, anti-inflammatory, and neuroprotective effects [52]. Luteolin shows positive effects on the migration and differentiation of porcine myoblasts through a mechanism related to the activation of the PI3K/Akt/mTOR signaling pathway [53]. Conclusion: challenges and future perspective In conclusion, this comprehensive synthesis of 20 natural products—mostly evaluated in vitro using horse, dog, and rabbit stem cells— highlights their therapeutic efficacy to effectively rescue MSC functionality in veterinary orthopedic, oncological, and metabolic models, such as EMS and diabetes (Fig. 1). By categorizing these agents into pure phytochemicals (icariin, icariside II, resveratrol, naringin, genistein, artemisinin, and berberine), medicinal plants (Panax notoginseng, Aloe vera, danshen, curcumin, rosemary, Artemisia annua, and henna), algal/microbial products (astaxanthin, Spirulina, Cladophora, and Haematococcus pluvialis), and nutraceuticals (soybean lecithin), it becomes evident that they orchestrate critical signaling axes such as PI3K/AKT/mTOR and Wnt/β-catenin to enhance stem cell therapeutic potential. These compounds offer cost-effective and accessible solutions for scalable regenerative applications. Schematic of natural products in veterinary MSCs therapy: summary of in vitro and in vivo evidence. EMS: equine metabolic syndrome, OSA: osteosarcoma; CMT: Canine mammary tumors Based on the synthesized data in Table 1, henna provides long-term antimicrobial stability, and soybean lecithin ensures membrane integrity against cold shock during cryopreservation. Looking ahead, the application of these bio-agents is emerging as a strategic tool in assisted reproductive technologies (ART). By enhancing sperm viability and preserving colony formation, such natural compounds are critical for the genetic preservation of endangered species and high-value veterinary resources. Moreover, in food biotechnology, bioactive compounds such as algae extracts and postbiotics are expected to play a dual role by enhancing skeletal muscle hypertrophy to increase conventional meat yield and by promoting myoblast differentiation in domestic animals—as functional feed additives—and in bioreactor-based cultured meat systems. Consequently, these compounds help address key environmental challenges, including greenhouse gas emissions and animal welfare concerns, while supporting sustainable protein production [54]. Despite the therapeutic benefits of natural products for veterinary MSC therapy, several critical challenges remain. Their limited solubility in organic solvents (such as acetone and ethanol) and dose-dependent toxicity often lead to batch-to-batch variations, inducing unexpected cytotoxicity and risking adverse clinical outcomes. Consequently, transitioning toward synergistic polypharmacology and species-specific dosing protocols will be essential to standardize these natural agents. Ultimately, the future of veterinary regenerative medicine must pivot toward the integration of nano-formulated phytochemicals (e.g., lipocurc (liposomal encapsulated curcumin) and smart delivery systems, such as PLLA scaffolds (e.g., genistein & matricaria chamomilla L. oil) and exosomes (e.g., Icariin & extracellular vesicles derived from rabbit synovial, Table 1), to enhance the bioavailability of lipophilic molecules. Furthermore, adopting 3D MSC culture systems to mimic complex in vivo organ interactions will provide superior accuracy for drug screening and mechanistic studies, ensuring more reliable clinical outcomes. Acknowledgements Not applicable. AI disclosure The authors declare that they have not use AI- generated work in this manuscript. Abbreviations Mesenchymal stem cells Adipose-derived mesenchymal stem cells Equine adipose-derived stem cells Bone marrow-derived mesenchymal stem cells Equine metabolic syndrome Osteoarthritis Intravenous Intra-arterial Intraperitoneal Author contributions ASH: Wrote, edited and submitted manuscript. Funding Not applicable. Data availability No datasets were generated or analysed during the current study. Declarations Ethics approval and consent to participate Not applicable. Consent for publication All authors agreed to publish this manuscript. Competing interests The authors declare no competing interests. Footnotes Publisher’s Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. References Associated Data Data Availability Statement No datasets were generated or analysed during the current study.